Thanks spid. Umm, I'm hesitant to write this post. There must be something I've misunderstood and I'm about to be the fool, with that in mind.
Unless I'm mistaken, the pdf says that the current SP (for the report) is $0.069 with a market cap of $23.8M. Their twelve month target is $0.225 with a market cap of $60.4M. Which represents a 226% increase.
I must be doing something wrong going by their figures. No analyst could get this wrong surely. However:
$23.8M divided by 0.069 = around 345M shares.
$60.4M divided by 0.225 = around 268M shares???
Err, I'm not aware of CAS announcing a share buyback program. I'm only aware of future dilution in the number of shares.
Also, I'm not sure what the 226% increase is supposed to match up with. Neither the SP or market cap match the 226% analysis target!
- Forums
- ASX - By Stock
- Ann: London Investment Bank Initiates Research on Crusader
Thanks spid. Umm, I'm hesitant to write this post. There must be...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online